United States Senate

Democratic Senators to Discuss Novo Nordisk’s Withdrawal of Levemir

Democratic Senators are set to meet with Novo Nordisk to discuss the withdrawal of long-acting insulin Levemir. The decision to discontinue Levemir has raised concerns, prompting lawmakers to seek clarification from the pharmaceutical company. Despite facing scrutiny, Novo Nordisk maintains that the move was not influenced by the success of its other products. The upcoming meeting reflects ongoing efforts to address pharmaceutical pricing and access to essential medications.

Sen. Josh Hawley Urges Hollywood to Honor Victims of America’s Nuclear Testing Programs

Conservative Sen. Josh Hawley (R-Mo.) is urging Hollywood to honor the victims of America’s nuclear testing programs as the critically acclaimed film ‘Oppenheimer’ garners attention ahead of the Oscars. The film, which has received 13 award nominations, is lauded for…